Skip to main content
TipRanks
Go Ultimate75% OFF

Sartorius Stedim Biotech (DIM) Stock Forecast & Price Target

20 Followers
See the Price Targets and Ratings of:

DIM Analyst Ratings

Strong Buy
6Ratings
6Buy0Hold0Sell
Based on 6 analysts giving stock ratings to Sartorius Stedim Biotech in the past 3 months

DIM Stock 12 Month Forecast

€257.67▲(15.44% Upside)
Based on 6 Wall Street analysts offering 12 month price targets for Sartorius Stedim Biotech in the last 3 months. The average price target is EUR 257.67 with a high forecast of EUR 275.00 and a low forecast of EUR 235.00. The average price target represents a 15.44% change from the last price of EUR 223.20.
Highest Price Target€275.00Average Price Target€257.67Lowest Price Target€235.00

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for FR:DIM
Price TargetArticle
Jefferies€266buy19.18%UpsideReiterated10/29/26
Goldman Sachs€223→€235buy5.29%UpsideReiterated10/23/26
J.P. Morgan€260buy16.49%UpsideReiterated10/22/26
RBC Capital€210→€275buy23.21%UpsideReiterated10/22/26
UBS€260buy16.49%UpsideReiterated10/15/26
Barclays€240→€250buy12.01%UpsideReiterated09/30/26
Bernstein€245→€230buy3.05%UpsideReiterated07/28/26
HSBC€233→€230buy3.05%UpsideReiterated06/03/26
Kepler Capital ―buy―Upgraded03/18/26
Stocks with the Highest Top Analyst Consensus in the General Sector
STDNStandard Nuclear
SKHYSK Hynix
ITGITG Inc. Class A
LIMENeutron Holdings, Inc.
EROCERock

Find stocks in the General sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Sartorius Stedim Biotech

3 Months
Charles Weston
Charles WestonRBC Capital
Success Rate12/14 ratings generated profit
86%
Average Return
+6.88%

Copying Charles Weston's trades and holding each position for 3 Months would result in 85.71% of your transactions generating a profit, with an average return of +6.88% per trade.

1 Year
Charles Weston
Charles WestonRBC Capital
Success Rate13/14 ratings generated profit
93%
Average Return
+15.95%

Copying Charles Weston's trades and holding each position for 1 Year would result in 92.86% of your transactions generating a profit, with an average return of +15.95% per trade.

2 Years
Success Rate10/10 ratings generated profit
100%
Average Return
+21.51%

Copying Charles Pitman CFA's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +21.51% per trade.

DIM Analyst Recommendation Trends

05101520Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for DIM
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy22100
Buy5681412
Hold11100
Sell00000
Strong Sell00000
total89101412

In the current month, DIM has received 12 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. DIM average Analyst price target in the past 3 months is 257.67.

DIM Financial Forecast

€0€0.5€1€1.5€2Q1 2026Q3 2026Q4 2026
High€1.54
Consensus€1.47
Low€1.39

DIM Earnings Forecast

Next quarter’s earnings estimate for DIM is EUR 1.47 with a range of EUR 1.39 to EUR 1.54. The previous quarter’s EPS was EUR 1.18. Its overall industry beat the EPS estimate 50.49% of the time in the past 12 months.

€761.5M€784.1M€806.8M€829.4M€852MQ1 2026Q3 2026Q4 2026
High€852M
Consensus€850M
Low€846M

DIM Sales Forecast

Next quarter’s sales forecast for DIM is EUR 849.52M with a range of EUR 845.90M to EUR 852.00M. The previous quarter’s sales results were EUR 762.10M. Its overall industry beat sales estimates 63.25% of the time in the past 12 months.

DIM Stock Forecast FAQ

What is FR:DIM’s average 12-month price target, according to analysts?
Based on analyst ratings, Sartorius Stedim Biotech’s 12-month average price target is €257.67.
What is FR:DIM’s upside potential, based on the analysts’ average price target?
Sartorius Stedim Biotech has 15.44% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Sartorius Stedim Biotech a Buy, Sell or Hold?
Sartorius Stedim Biotech has a consensus rating of Strong Buy, which is based on 6 buy ratings, 0 hold ratings and 0 sell ratings.
What is Sartorius Stedim Biotech’s share price target?
The average share price target for Sartorius Stedim Biotech is €257.67. This is based on 6 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €275.00, and the lowest forecast is €235.00. The average share price target represents a 15.44% increase from the current price of €223.2.
What do analysts say about Sartorius Stedim Biotech?
Sartorius Stedim Biotech’s analyst rating consensus is a Strong Buy. This is based on the ratings of 6 Wall Street analysts.
How can I buy shares of Sartorius Stedim Biotech?
To buy shares of FR:DIM, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.